Could ketogenic diet “starve” cancer? Emerging evidence
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Cancer cells (CCs) predominantly use aerobic glycolysis (Warburg effect) for their metabolism. This important characteristic of CCs represents a potential metabolic pathway to be targeted in the context of tumor treatment. Being this mechanism related to nutrient oxidation, dietary manipulation has been hypothesized as an important strategy during tumor treatment. Ketogenic diet (KD) is a dietary pattern characterized by high fat intake, moderate-to-low protein consumption, and very-low-carbohydrate intake (<50 g), which in cancer setting may target CCs metabolism, potentially influencing both tumor treatment and prognosis. Several mechanisms, far beyond the originally proposed inhibition of glucose/insulin signaling, can underpin the effectiveness of KD in cancer management, ranging from oxidative stress, mitochondrial metabolism, and inflammation. The role of a qualified Nutritionist is essential to reduce and manage the short and long-term complications of this dietary therapy, which must be personalized to the individual patient for the planning of tailored KD protocol in cancer patients. In the present review, we summarize the proposed antitumor mechanisms of KD, the application of KD in cancer patients with obesity and cachexia, and the preclinical and clinical evidence on KD therapy in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177 · cited 1×
“In particular, CCs have a proliferation rate higher than the growth rate of new blood vessel generation, therefore newly formed CCs are supplied with lower amount of oxygen; in this way, in order to survive, CCs adapt to the low oxygen environment (Harris 2002).”
BackgroundThe Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088 · cited 1×
“There is evidence that ATP supply is never limited in these cells, despite the degree of differentiation, cells using aerobic glycolysis also exhibit high ratios of ATP/adenosine diphosphate and NADH/nicotinamide adenine dinucleotide (NAD)þ (Christofk et al. 2008; DeBerardinis et al. 2008).”
BackgroundKim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905 · cited 1×
“In particular, HIF-1 blocks the function of pyruvate dehydrogenase enzyme resulting in the production of lactate through the expression of pyruvate dehydrogenase kinase 1 (Kim et al. 2006).”
BackgroundInflammation and cancer: triggers, mechanisms, and consequences
Greten, F. R., & Grivennikov, S. I. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.025 · Cited by 3,806 · cited 1×
“…and stage, is initiated through the acute-phase response by the hepatic tissue in response to cancer or by the secretion of inflammatory cytokines by the cancer itself (Diakos et al. 2014; Greten and Grivennikov 2019), that promotes cancer progression and its invasive capacity (Sowers et al. 2014).”
BackgroundESPEN guidelines on nutrition in cancer patients
Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., Fearon, K., Hütterer, E., Isenring, E., Kaasa, S., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2016.07.015 · Cited by 3,114
Fundamentals of Cancer Metabolism
DeBerardinis, R. J., & Chandel, N. S. (2016) · Science Advances · doi:10.1126/sciadv.1600200 · Cited by 3,013 · cited 2×
“The rapid growth of CCs requires very high functional mitochondria to support the increased energy expenditure by the cell; thus, oncogenic lesions are likely to modify the metabolism used by mitochondria to sustain tumor growth (De Berardinis and Chandel 2016).”
BackgroundThe M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820 · cited 7×
“ATP adenosine triphosphate BMI body mass index CC cancer cell DON 6-diazo-5-oxo-L-norleucine ESPEN European Society for Clinical Nutrition and Metabolism GLUT glucose transporters HIF-1 hypoxia-inducible factor 1 IGF insulin-like growth factor KD ketogenic diet mTOR mammalian target of the rapamycin NAD nicotinamide a…”
BackgroundInfluentialCancer cell metabolism: warburg and beyond
Hsu, P. P., & Sabatini, D. M. (2008) · Cell · doi:10.1016/j.cell.2008.08.021 · Cited by 2,452 · cited 1×
“In addition, recent studies have shown that increased use of glucose by CCs is an adaptive response to mitochondrial oxidative stress (Bose and Le 2018; Brault and Schulze 2016; Hsu and Sabatini 2008).”
BackgroundTumor cell metabolism: cancer's Achilles' heel
Kroemer, G., & Pouyssegur, J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.005 · Cited by 2,337
Cited by
Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer
Kasprzak, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126434 · Cited by 248
Reytor-González, C., Simancas-Racines, D., Román-Galeano, N. M., Annunziata, G., Galasso, M., Zambrano-Villacres, R., Verde, L., Muscogiuri, G., Frias-Toral, E., & Barrea, L. (2025) · Nutrients · doi:10.3390/nu17132135 · Cited by 88
Self-citationVLCKD: a real time safety study in obesity
Barrea, L., Verde, L., Vetrani, C., Marino, F., Aprano, S., Savastano, S., Colao, A., & Muscogiuri, G. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-021-03221-6 · Cited by 47
Self-citationKetogenic diet and multiple health outcomes: an umbrella review of meta-analysis
Chen, S., Su, X., Feng, Y., Li, R., Liao, M., Fan, L., Liu, J., Chen, S., Zhang, S., Cai, J., et al. (2023) · Nutrients · doi:10.3390/nu15194161 · Cited by 41
Very Low Calorie Ketogenic Diet: What Effects on Lipid Metabolism?
Suarez, R., Chapela, S., Llobera, N. D., Montalván, M., Vásquez, C. A., Martinuzzi, A. L. N., Katsanos, C. S., Verde, L., Frias-Toral, E., Barrea, L., et al. (2024) · Current Nutrition Reports · doi:10.1007/s13668-024-00556-6 · Cited by 20
Self-citation
Metadata
- Authors
- Barrea, L., Caprio, M., Tuccinardi, D., Moriconi, E., Di Renzo, L., Muscogiuri, G., Colao, A., Savastano, S., & on behalf of the Obesity Programs of nutrition, E.
- Venue
- Critical Reviews in Food Science and Nutrition
- Publisher
- Informa UK Limited
- Published
- 2020-12-04
- Volume
- 62
- Issue
- 7
- Pages
- 1800-1821
- ISSN
- 1040-8398 (ISSN-L)
- 1549-7852
- OpenAlex
- W3109012312
- Cited by
- 102
- References
- 47
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Could ketogenic diet “starve” cancer? Emerging evidence. https://app.cochat.ai/papers/10.1080/10408398.2020.1847030
- The paper
- Barrea, L., Caprio, M., Tuccinardi, D., Moriconi, E., Di Renzo, L., Muscogiuri, G., Colao, A., Savastano, S., & on behalf of the Obesity Programs of nutrition, E. (2022). Could ketogenic diet “starve” cancer? Emerging evidence. Critical Reviews in Food Science and Nutrition. https://doi.org/10.1080/10408398.2020.1847030
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.